BAILEY SCALZI: Open Payments
NPI 1891417713 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 53 payments from 14 companies in 2025. Trend: 2023 $6,656 · 2024 $4,011 · 2025 $1,511
Food & beverage: $1,411Education: $100
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 12 | $379 |
| Janssen Biotech, Inc. | 10 | $282 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $217 |
| GENZYME CORPORATION | 5 | $184 |
| Amgen Inc. | 6 | $165 |
| Lilly USA, LLC | 3 | $78 |
| ABBVIE INC. | 4 | $74 |
| UCB, Inc. | 1 | $25 |
| Incyte Corporation | 1 | $25 |
| Biofrontera Inc. | 1 | $19 |
Products named: Zoryve, TREMFYA, DUPIXENT, ILUMYA, SKYRIZI, TALTZ, OTEZLA, BLU-U.
Industry payments across FL — which companies pay providers there.
